Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival
Overall Response Rate was 38.1% vs. 12.0% for the ARPI switch arm, including 9.3% Complete Responses
Patients demonstrated statistically significant improvement in time to reduction of health-related quality of life (HRQoL) as measured by Functional Assessment of Cancer Therapy—Prostate (FACT-P)
Interim Overall Survival Crossover Adjusted Hazard Ratio was